IBS News

Subscribe to IBS News feed
IBS Patient Group Community - IBSpatient.org - IBS News
Updated: 1 hour 22 min ago

Google-IBS symptoms: Pain and bloating could be caused by fibromyalgia - what is the condition? - Express.co.uk

Apr 24, 2018
Express.co.uk IBS symptoms: Pain and bloating could be caused by fibromyalgia - what is the condition? Express.co.uk IBS, which stands for irritable bowel syndrome, can develop at any age, but the symptoms usually start to advance between the ages of 20 and 30 years old, and are most prevalent in women. The condition is a common, long-term disorder which affects the ... View the full article

Medical News Today-What home remedies can stop flatulence?

Apr 24, 2018
Although passing gas is a normal bodily function, some people may be concerned that they do so excessively. There are many steps that can help to reduce flatulence, including dietary changes and supplements. In this article, we look at 12 steps that could help reduce farting, and when excess gas may be more worrying. View the full article

Pubmed-Nocebo Effects and Experimental Models in Visceral Pain.

Apr 24, 2018
Related Articles Nocebo Effects and Experimental Models in Visceral Pain. Int Rev Neurobiol. 2018;138:285-306 Authors: Elsenbruch S, Labrenz F Abstract Despite its clinical relevance and the potential to extend insights into the processing and modulation of pain derived from investigations of placebo phenomena, the nocebo effect has received comparably little attention over the past decades. Research from experimental and clinical studies is only beginning to unravel the behavioral, functional, and psychoneurobiological mechanisms underlying the nocebo effect. Herein, we summarize current evidence regarding nocebo effects in the field of pain, with a particular emphasis on visceral pain. We provide an overview over behavioral and neuroimaging findings on the impact of expectations and learning and propose promising future directions to help fostering the transition of experimental research from bench to bedside. PMID: 29681331 [PubMed - in process] View the full article

Pubmed-Alexithymia in Gastroenterology and Hepatology: A Systematic Review.

Apr 24, 2018
Related Articles Alexithymia in Gastroenterology and Hepatology: A Systematic Review. Front Psychol. 2018;9:470 Authors: Carrozzino D, Porcelli P Abstract Background: Alexithymia is a multifaceted personality construct that represents a deficit in the cognitive processing of emotions and is currently understood to be related to a variety of medical and psychiatric conditions. The present review aims to investigate the relationship of alexithymia with gastrointestinal (GI) disorders as functional gastrointestinal disorders (FGID, as irritable bowel syndrome (IBS) and functional dyspepsia) and inflammatory bowel disease (IBD) [ulcerative colitis (UC) and Crohn's disease (CD)] and liver diseases as chronic hepatitis C (CHC), cirrhosis, and liver transplantation. Methods: The articles were selected from the main electronic databases (PsycInfo, Medline, PubMed, Web of Science, Scopus, Cochrane, and ScienceDirect) using multiple combinations of relevant search terms (defined GI and liver diseases, articles in English, use of the Toronto scales [TAS] for alexithymia). The TAS was selected as inclusion criterion because it is the most widely used measure, thus allowing comparisons across studies. Results: Forty-eight studies met the inclusion criteria, of which 38 focused on GI disorders (27 on FGID and 11 on IBD) and 10 on liver diseases. Most studies (n = 30, 62%) were cross-sectional. The prevalence of alexithymia was higher in FGID (two third or more) than IBD and liver diseases (from one third to 50% of patients, consistent with other chronic non-GI diseases) than general population (10-15%). In functional disorders, alexithymia may be viewed as a primary driver for higher visceral perception, symptom reporting, health care use, symptom persistence, and negative treatment outcomes. Also, it has been found associated with psychological distress and specific GI-related forms of anxiety in predicting symptom severity as well as post-treatment outcomes and is associated with several psychological factors increasing the burden of disease and impairing levels of quality of life. A number of critical issues (small sample sizes, patients referred to secondary and tertiary care centers, cross-sectional study design, use of one single scale for alexithymia) constitutes a limitation to the generalization of findings. Conclusions: Alexithymia showed to play different roles in gastroenterology according to the clinical characteristics and the psychological burden of the various disorders, with main relevance in increasing subjective symptom perception and affecting negatively post-treatment outcomes. PMID: 29681874 [PubMed] View the full article

Pubmed-Functions and Signaling Pathways of Amino Acids in Intestinal Inflammation.

Apr 24, 2018
Related Articles Functions and Signaling Pathways of Amino Acids in Intestinal Inflammation. Biomed Res Int. 2018;2018:9171905 Authors: He F, Wu C, Li P, Li N, Zhang D, Zhu Q, Ren W, Peng Y Abstract Intestine is always exposed to external environment and intestinal microorganism; thus it is more sensitive to dysfunction and dysbiosis, leading to intestinal inflammation, such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and diarrhea. An increasing number of studies indicate that dietary amino acids play significant roles in preventing and treating intestinal inflammation. The review aims to summarize the functions and signaling mechanisms of amino acids in intestinal inflammation. Amino acids, including essential amino acids (EAAs), conditionally essential amino acids (CEAAs), and nonessential amino acids (NEAAs), improve the functions of intestinal barrier and expressions of anti-inflammatory cytokines and tight junction proteins but decrease oxidative stress and the apoptosis of enterocytes as well as the expressions of proinflammatory cytokines in the intestinal inflammation. The functions of amino acids are associated with various signaling pathways, including mechanistic target of rapamycin (mTOR), inducible nitric oxide synthase (iNOS), calcium-sensing receptor (CaSR), nuclear factor-kappa-B (NF-κB), mitogen-activated protein kinase (MAPK), nuclear erythroid-related factor 2 (Nrf2), general controlled nonrepressed kinase 2 (GCN2), and angiotensin-converting enzyme 2 (ACE2). PMID: 29682569 [PubMed - in process] View the full article

Pubmed-The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.

Apr 24, 2018
The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study. J Affect Disord. 2018 Apr 12;235:506-512 Authors: Kurokawa S, Kishimoto T, Mizuno S, Masaoka T, Naganuma M, Liang KC, Kitazawa M, Nakashima M, Shindo C, Suda W, Hattori M, Kanai T, Mimura M Abstract BACKGROUNDS: The intestinal microbiota is considered as a potential common underpinning pathophysiology of Functional Gastrointestinal Disorders (FGIDs) and psychiatric disorders such as depression and anxiety. Fecal Microbiota Transplantation (FMT) has been reported to have therapeutic effects on diseases related to dysbiosis, but few studies have evaluated its effect on psychiatric symptoms. METHODS: We followed 17 patients with either Irritable Bowel Syndrome (IBS), Functional Diarrhea (FDr) or Functional Constipation (FC) who underwent FMT for the treatment of gastrointestinal symptoms and observation of psychiatric symptoms. Changes in Hamilton Rating Scale for Depression (HAM-D) and subscale of sleep-related items, Hamilton Rating Scale for Anxiety (HAM-A) and Quick Inventory for Depressive Symptoms (QIDS) between baseline and 4 weeks after FMT, and relationship with the intestinal microbiota were measured. RESULTS: At baseline, 12 out of 17 patients were rated with HAM-D ≥ 8. Significant improvement in HAM-D total and sleep subscale score, HAM-A and QIDS were observed (p = 0.007, p = 0.007, p = 0.01, p = 0.007, respectively). Baseline Shannon index indicated that microbiota showed lower diversity in patients with HAM-D ≥ 8 compared to those of healthy donors and patients with HAM-D < 8. There was a significant correlation between baseline Shannon index and HAM-D score, and a correlation between Shannon index change and HAM-D improvement after FMT. LIMITATIONS: The small sample size with no control group. CONCLUSIONS: Our results suggest that depression and anxiety symptoms may be improved by FMT regardless of gastrointestinal symptom change in patients with IBS, FDr and FC, and the increase of microbiota diversity may help to improve patient's mood. PMID: 29684865 [PubMed - as supplied by publisher] View the full article

Twitter-RT @TippedMug: Join @IFFGD and the @CrohnsColitisFn tomorrow at 8 PM EST for a Twitter chat on #IBS, #IBD, and the overlap between these of…

Apr 23, 2018
RT @TippedMug: Join @IFFGD and the @CrohnsColitisFn tomorrow at 8 PM EST for a Twitter chat on #IBS, #IBD, and the overlap between these of… (RSS generated with FetchRss) View the full article

Study finds IBS patients obtain enduring relief from home-based treatment program - University at Buffalo Reporter

Apr 23, 2018
EurekAlert (press release) Study finds IBS patients obtain enduring relief from home-based treatment program University at Buffalo Reporter In the largest federally funded, non-drug, clinical trial for irritable bowel syndrome (IBS), patients with the most severe and persistent symptoms achieved robust and sustained relief by learning to control symptoms with minimal clinician contact. Led ... IBS patients obtain robust, enduring relief from home-based treatment programEurekAlert (press release) all 3 news articles » View the full article

Twitter-RT @casa_desante: The latest *The FODMAP Daily*! https://t.co/YFPCmuPJPs Thanks to @sbrosek @KateScarlata_RD @umfoodoc #ibs #nutrition

Apr 22, 2018
RT @casa_desante: The latest *The FODMAP Daily*! https://casadesante.com/pages/the-low-fodmap-daily Thanks to @sbrosek @KateScarlata_RD @umfoodoc #ibs #nutrition (RSS generated with FetchRss) View the full article

Google-3 reasons you can't get your IBS under control, according to a dietitian - Body and Soul

Apr 22, 2018
Body and Soul 3 reasons you can't get your IBS under control, according to a dietitian Body and Soul It impacts nearly 20 percent of the popular so here's how to stop those symptoms from flaring up. Kolkata | IBS is the 2nd most common cause of work absenteeism ...The Echo of India all 5 news articles » View the full article

Twitter-RT @OPBMed: However the @RomeFoundation Psychogastroenterology Group, headed by @drlauriekeefer and @drkinsinger are forging the way for he…

Apr 22, 2018
RT @OPBMed: However the @RomeFoundation Psychogastroenterology Group, headed by @drlauriekeefer and @drkinsinger are forging the way for he… (RSS generated with FetchRss) View the full article

Google-Biomarkers for irritable bowel syndrome - Medical Xpress

Apr 22, 2018
Medical Xpress Biomarkers for irritable bowel syndrome Medical Xpress Over the course of eight years, an interdisciplinary team with several clinics in Europe led by Professor Michael Schemann from the Department of Human Biology at TUM searched for a putative biomarker to identify organic changes in irritable bowel ... View the full article

Twitter-RT @bayskitchenuk: Our countdown continues... just two days until we launch our new #lowfodmap #vegan delicious… https://t.co/KKzy3VYZ3T

Apr 22, 2018
RT @bayskitchenuk: Our countdown continues... just two days until we launch our new #lowfodmap #vegan delicious… https://www.instagram.com/p/Bh02aoiHvqx/ (RSS generated with FetchRss) View the full article

Twitter-RT @pruvwellness: Fabulous Low FODMAP sauces from the totally awesome @bayskitchenuk launching tomorrow and available from the Pruv Emporiu…

Apr 22, 2018
RT @pruvwellness: Fabulous Low FODMAP sauces from the totally awesome @bayskitchenuk launching tomorrow and available from the Pruv Emporiu… (RSS generated with FetchRss) View the full article

Google-3 reasons you can't get you IBS under control, according to a dietitian - Body and Soul

Apr 22, 2018
Body and Soul 3 reasons you can't get you IBS under control, according to a dietitian Body and Soul Did you know that April is IBS awareness month? That, and with so much interest in the role our gut plays in good health, if you have IBS, there is no time like the present to get your IBS under control. Irritable bowel Syndrome (IBS) affects ... IBS is the 2nd most common cause of work absenteeism: SurveyThe Echo of India all 5 news articles » View the full article

Twitter-RT @GIdietitian: So important to address the patient’s goals for visit. I’ve had to restructure my planned teaching points many times to be…

Apr 22, 2018
RT @GIdietitian: So important to address the patient’s goals for visit. I’ve had to restructure my planned teaching points many times to be… (RSS generated with FetchRss) View the full article

Google-IBS is the 2nd most common cause of work absenteeism: Survey - The Echo of India

Apr 22, 2018
IBS is the 2nd most common cause of work absenteeism: Survey The Echo of India A study conducted by the HCFI, a National Health NGO has revealed that about 5-10% of the population surveyed experiences symptoms of Irritable Bowel Syndrome (IBS) such as abdominal pain, diarrhea, constipation or incomplete evacuation. Yet, a ... and more » View the full article

Pubmed-Bowel symptoms in patients that receive proton pump inhibitors. Results of a multicenter survey in Mexico.

Apr 22, 2018
Related Articles Bowel symptoms in patients that receive proton pump inhibitors. Results of a multicenter survey in Mexico. Rev Gastroenterol Mex. 2018 Apr 17;: Authors: Schmulson MJ, Frati-Munari AC Abstract INTRODUCTION: Proton pump inhibitors (PPIs) have been associated with small intestinal bacterial overgrowth (SIBO), which increases with prolonged PPI use, and SIBO has been associated with irritable bowel syndrome (IBS). OBJECTIVE: The aim of the present study was to study the prevalence of bowel symptoms in patients treated with PPIs in Mexico. METHODS: Gastroenterologists in 36 cities surveyed patients treated with PPIs, utilizing an ad hoc questionnaire to determine the presence of bowel symptoms and IBS. RESULTS: Two hundred and fifteen physicians interviewed 1,851 patients. PPI indications were gastritis (48.8%), gastroesophageal reflux (38.5%), peptic ulcer (6.2%), and others (6.5%). A total of 77.5% of the patients received treatment for ≤6 months and 11.9% for ≥1 year. Symptoms were reported in 92.3% of the patients: abnormal bowel habits (90%), bloating (82%), abdominal pain (63%), flatulence (58%), and abdominal discomfort (53%). A total of 67.5% of the patients fit the Rome III criteria for IBS. Symptoms presented in 55.9% of the patients before PPI intake and in 44.1% of the patients after PPI use (P<.005). Constipation (63.8%) predominated in the former, and diarrhea (56.5%) in the latter (P<.0001). The treatments prescribed for managing those symptoms were antispasmodics, antibiotics, prokinetics, and antiflatulents, but patients stated greater satisfaction with antibiotics (mainly rifaximin) (P<.0001). CONCLUSION: The association of PPIs with bowel symptoms and IBS is frequent in Mexico. Diarrhea and bloating predominate, and antibiotics produce the greatest treatment satisfaction, suggesting that SIBO or dysbiosis is the cause of the PPI-related bowel symptoms. However, that remains to be confirmed. PMID: 29678362 [PubMed - as supplied by publisher] View the full article

Google-Irritable Bowel Syndrome is second - Free Press Journal

Apr 22, 2018
Irritable Bowel Syndrome is second Free Press Journal Mumbai : A study conducted by the Heart Foundation of India (HCFI), a leading national health NGO has revealed that about 5 to 10 per cent of the population surveyed experiences symptoms of Irritable Bowel Syndrome (IBS) such as abdominal pain ... View the full article

Twitter-Thanks for sharing this! #mastcells #IBS. https://t.co/rk6tf0VEDq

Apr 21, 2018
Thanks for sharing this! #mastcells #IBS. https://twitter.com/umfoodoc/status/987735198614908928 (RSS generated with FetchRss) View the full article

Pages